Collagen Matrix, Inc. Receives FDA 510(k) Clearance for SynOss(TM) Synthetic Mineral Bone Graft Material

FRANKLIN LAKES, N.J., Nov 5. Collagen Matrix, Inc.announces that it has received FDA's 510(k) clearance of its SynOss(TM)Synthetic Mineral bone graft material intended for use in oral surgicalapplications involving bone repair.

SynOss Synthetic Mineral is an osteoconductive calcium phosphate basedbone graft material with an apatite structure similar to that of human bone.Unlike hydroxyapatite materials, SynOss' has a carbonate apatite structurewhich is comparable to the mineralized matrix structure of human bone. Thesimilarity in structure between SynOss and natural bone mineral allows forSynOss' in vivo resorption and remodeling profile to mimic that of naturalbone.

The synthetic mineral product is complementary to the Company's existingline of products intended for dental and oral surgery, which include CollagenDental Membranes, Anorganic Bone Mineral, Anorganic Bone Mineral withCollagen, and Collagen Dental Wound Dressings in various forms (i.e., Foam,Tape, Plug, and Microfibrillar). These products are sold through partnershipswith major companies in the dental market.

"Our goal is to provide the dental and oral surgical markets with a fullline of innovative products for use in regenerative medicine. The addition ofSynOss is another step in reaching that goal," said Shu-Tung Li, Ph.D.,Founder and CEO of Collagen Matrix.

About Collagen Matrix

A Franklin Lakes, NJ based, privately-held, leading collagen- andmineral-based biomaterials company, Collagen Matrix, Inc. has applied itsexpertise in proprietary matrix engineering to develop and commercialize novelimplants for tissue and organ repair and regeneration. The Company currentlymanufactures collagen- and mineral-based finished medical devices in areas oforal surgery, neurosurgery, orthopedic-spine surgery, and wound care. Over 20products are currently being marketed directly or through partnerships withsome of the world's major medical device companies. In addition to theproducts in the oral surgical area, Collagen Matrix's marketed productsinclude: DuraMatrix(TM) for dural repair, Neuroflex(TM), NeuroMatrix(TM) forperipheral nerve repair, OssiMend(TM) for bone repair in orthopedics andspine, and the Matrix Collagen Family of Products for wound care. For moreinformation, visit www.collagenmatrix.com.Contact: Shu-Tung Li, Ph.D. 888-405-1001 201-405-1477

SOURCE Collagen Matrix, Inc.

Latest Press Release on General News

Precision oncology company Flindr Therapeutics announces €20 million Series A financing to advance first-in-class small molecule inhibitors

V-Bio Ventures leads international syndicate which includes Johnson & Johnson Innovation – JJDC, Inc., QBIC Fund, Flanders Future Tech Fund, Curie Capital as well as seed investor...

Rett Syndrome Research Trust Partners with Vivalink to Shift Symptom Assessment Paradigms in Rett Syndrome

Vivalink's remote patient monitoring solutions accelerate research into rare neurological disorder CAMPBELL, Calif. , April 23, 2024 /PRNewswire/ -- Vivalink , a leading pro...

World IBS Day - April 19th: Raising Awareness for Everyone with IBS

Debunking myths about Irritable Bowel Syndrome TORONTO , April 18, 2024 /PRNewswire/ -- IBS is a chronic gastrointestinal disorder with symptoms like abdominal pain, bloating,...

Important step taken on the Canada Disability Benefit in Budget 2024, but funding falls short

More work must be done to lift Canadians with disabilities out of poverty TORONTO , April 17, 2024 /CNW/ - The federal government has taken an important step on the Canada Di...

Hydrinity Accelerated Skin Science Introduces MicroFusion Technology and Expands Facial Skincare Line with PRELUDE Facial Treatment Cleanser and HYDRI-C Vitamin C Moisturizer

The Next Generation Technology with the Power to Transform Skin MONROE, La. , April 15, 2024 /PRNewswire/ -- Hydrinity Accelerated Skin Science announced today the launch of t...